ArticleInfectious diseases and therapy2022

Impact of Ceftolozane-Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections.

Dana J Holger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.